CAS Medical Systems (CASM) Narrows Q4 Loss

CAS Medical Systems (NASDAQ: CASM) reported Q4 EPS of ($0.08), versus ($0.11) reported last year. Revenue for the quarter came in at $5.8 million, versus $5.2 million reported last year.

For earnings history and earnings-related data on CAS Medical Systems (CASM) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance